News

RxPONDER Radiotherapy Analysis at ASTRO 2022
Press Release
Oct 24, 2022

Radiotherapy and Recurrence in RxPONDER Trial

SWOG Front Line banner
The Front Line
Sep 30, 2022

Lyman Stepping Down as EO; Sun Stepping Up

SWOG Front Line banner
The Front Line
Sep 23, 2022

A Call for Candidates

The SWOG group chair nominating process is underway.
SWOG Front Line banner
The Front Line
Sep 16, 2022

The Word of the Day is "Neoadjuvant"

S1801 Melanoma Results at ESMO 2022
Press Release
Sep 11, 2022

Neoadjuvant IO Boosts High-Risk Melanoma EFS

SWOG researchers have found that starting pembrolizumab before surgery instead of waiting until after surgery significantly improves the outlook for patients with stage III-IV melanoma.
SWOG Front Line banner
The Front Line
Sep 9, 2022

Meet the Staff: Courtney Wille, Meetings Mgr

SWOG Front Line banner
The Front Line
Aug 26, 2022

Trial Tests Genomic Tumor Board Impact, Reach

SWOG Front Line banner
The Front Line
Aug 12, 2022

Honoring Dr. Nicholas Vogelzang

A lung cancer precision medicine trial: Lung-MAP
Announcement
Jul 27, 2022

Lung-MAP Summer 2022 Newsletter

The summer 2022 issue of the Lung-MAP Newsletter is now online.